Epidemiological profile of the Mpox virus in Africa

The Mpox pandemic has currently spread to at least 120 countries globally. While few deaths linked to this outbreak have occurred, the Mpox virus could spread in hospital outbreaks compared to household outbreaks, underscoring the need to enhance infection prevention and control measures in healthcare settings. Children under 15 and individuals living with HIV are particularly susceptible to severe Mpox infection due to their compromised immune systems. As such, preventative and control interventions should target these groups due to their high transmission potential. Vaccines such as MVA-BN vaccines are effective when administered in two doses, and antiviral agents are effective in managing symptoms and reducing hospital stays.

Attached Files

File	Action
Epidemiological profile of the Mpox virus in Africa.pdf	Download

ACAM2000 Brincidofovir JYNNEOS Mpox virus MVA-BN vaccines